Company / R&D Expense
DNA X, Inc. R&D Expense History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$1.8M
FY2024
5-year range
$1.8M / $26.1M
FY2020-FY2024
Trend
-77.8%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has fluctuated over the past 6 years, ranging from $2M in FY2024 to $26M in FY2020.
Based on SEC 10-K filings.
$2M in FY2024 with a 5-year CAGR of -40.2%.
Declined from $18M to $2M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -52.2%
- 5-Year CAGR
- -40.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -40.2%, indicating a declining trend.
- In FY2024, r&d expense decreased 77.8% year-over-year.
- Peak r&d expense was recorded in FY2020.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.8M | -77.8% |
| FY2023 | $8.0M | -54.9% |
| FY2022 | $17.7M | +9.1% |
| FY2021 | $16.2M | -37.8% |
| FY2020 | $26.1M | +12.1% |
| FY2019 | $23.2M | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026